Growth Metrics

BeOne Medicines (ONC) Interest Expenses (2016)

BeOne Medicines (ONC) has disclosed Interest Expenses for 2 consecutive years, with $284000.0 as the latest value for Q3 2016.

  • On a quarterly basis, Interest Expenses fell 5.33% to $284000.0 in Q3 2016 year-over-year; TTM through Jun 2017 was $284000.0, a 55.97% decrease, with the full-year FY2025 number at $58.2 million, up 167.07% from a year prior.
  • Interest Expenses was $284000.0 for Q3 2016 at BeOne Medicines, up from $141000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $300000.0 in Q3 2015 to a low of $141000.0 in Q2 2016.